ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Screening"

  • 2019 American Transplant Congress

    Uterus Transplantation: Recipient Surgery

    L. Johannesson, A. Wall, J. Bayer, G. J. McKenna, G. Testa

    Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX

    *Purpose: The field of uterus transplantation, since the first birth to a uterus transplanted woman in 2014, continues to grow rapidly. As of today at…
  • 2019 American Transplant Congress

    Lower Stanford Integrated Psychosocial Assessment (SIPAT) for Transplantation Score is Predictive of Successful Listing for Kidney Transplant Candidates

    A. Kumar1, J. Salaway2, M. Dorris2, J. Newman3, A. Doyle1, S. Rao1

    1Nephrology, University of Virginia, Charlottesville, VA, 2Transplant, University of Virginia, Charlottesville, VA, 3University of Virginia, Charlottesville, VA

    *Purpose: Psychosocial evaluation is an integral part of transplant recipient evaluation. SIPAT is a tool designed to assess psychological health of transplant candidates. Lower SIPAT…
  • 2019 American Transplant Congress

    Liquid Biopsy for Chronic Rejection after Kidney Transplantation. A Novel Non-Invasive Biomarker Involved in Inflammatory Amplifier

    Y. Takada1, D. Kamimura2, H. Higuchi1, D. Iwami1, K. Hotta1, N. Iwahara1, N. Shinohara1, M. Murakami2

    1Renal and Genitourinary Surgery, Hokkaido University Hospital, Sapporo, Japan, 2Molecular Psychoimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan

    *Purpose: In kidney transplantation (KTx), despite recent advances of medical technology, chronic rejection accounts for 25% of the graft loss. Chronic active antibody-mediated rejection (CAAMR)…
  • 2019 American Transplant Congress

    Outcomes for Lung Transplantation Recipients with Non-Alcoholic Fatty Liver Disease

    A. J. Trindade1, P. Burkett1, S. El-Chemaly1, N. Hashemi2, T. Thaniyavarn1, H. R. Mallidi3, H. J. Goldberg1

    1Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, 2Gastroenterology and Hepatology, Brigham and Women's Hospital, Boston, MA, 3Division of Thoracic and Cardiovascular Surgery, Brigham and Women's Hospital, Boston, MA

    *Purpose: Non-alcoholic Fatty Liver Disease (NAFLD) afflicts ~20-40% people in the western world and is a risk factor for comorbidities prevalent in the lung transplant…
  • 2019 American Transplant Congress

    Illustration of Renal Recovery in SLK with Utilization of Most Recent Allocation Criteria

    B. Patel, R. Prashar, A. Babu

    Henry Ford Hospital Detroit, Detroit, MI

    *Purpose: Single Center review of Renal recovery in Simultaneous Liver Kidney Transplantation (SLKT) in patients who were approved for SLK based on the recent UNOS…
  • 2019 American Transplant Congress

    Frailty is Highly Prevalent in Lung Transplant Candidates and Varies by Frailty Tool

    A. O'Boye, K. Leitner, M. Kelly, J. Wright, J. Lee, M. Sala, R. Tomic, S. Bhorade

    Northwestern Memorial Hospital, Chicago, IL

    *Purpose: Lung transplantation is a lifesaving therapy in patients with advanced lung disease. However, frail lung transplant candidates are more likely to be delisted or…
  • 2019 American Transplant Congress

    Liver Transplant Centers Select Different Characteristics for Recipients and Deceased Donors: Implications for Patients When Choosing a Center

    C. R. Schaffhausen1, M. J. Bruin2, S. Chu2, D. Schladt1, S. Chinnakotla3, J. R. Lake4, W. Kim5, S. W. Biggins6, J. J. Snyder7, B. L. Kasiske7, A. K. Israni1

    1Hennepin Healthcare Research Institute, Minneapolis, MN, 2College of Design, University of Minnesota, Minneapolis, MN, 3Department of Surgery, University of Minnesota, Minneapolis, MN, 4Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, MN, 5Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA, 6Division of Gastroenterology, University of Washington, Seattle, WA, 7Scientific Registry of Transplant Recipients, Minneapolis, MN

    *Purpose: When patients can choose the liver transplant center at which to establish care, a prior knowledge of center acceptance practices (of candidates and donors)…
  • 2019 American Transplant Congress

    Introduction of Universal Hepatitis E RNA Screening in Deceased Organ Donors – The UK Experience

    I. Ushiro-Lumb1, K. Tettmar1, I. Johannessen2, K. Simpson2, I. Hart3, J. Timms4, A. Hale5, S. Ijaz6, R. Tedder6, J. Forsythe1

    1NHS Blood and Transplant, London, United Kingdom, 2Royal Infirmary of Edinburgh, Edinburgh, United Kingdom, 3Royal Liverpool University Hospital, Liverpool, United Kingdom, 4University Hospitals Coventry and Warwickshire, Coventry, United Kingdom, 5Public Health England, Leeds, United Kingdom, 6Public Health England, London, United Kingdom

    *Purpose: We aim to describe the strategy and initial results of post-donation, universal screening of deceased organ donors in the UK. HEV RNA is tested…
  • 2019 American Transplant Congress

    Preoperative Risk Factor-based Cardiac Catheterization Is Associated With Low Cardiac Morbidity And Mortality In Liver Transplant Patients

    R. Rachwan1, I. Kutkut1, P. D. Bourdillon2, L. R. Timsina3, M. Ghabril4, C. A. Kubal5, M. A. Lacerda6, R. S. Mangus5

    1Internal Medicine, Indiana University, Indianapolis, IN, 2Internal Medicine, Indiana University, Division of Cardiology, Indianapolis, IN, 3Department of Biostatistics, Indiana University, Indianapolis, IN, 4Internal Medicine, Indiana University, Division of Hepatology, Indianapolis, IN, 5Surgery, Transplant Division, Indiana University, Indianapolis, IN, 6Internal Medicine, Division of Hepatology, Indiana University, Indianapolis, IN

    *Purpose: Mortality post-liver transplant historically was largely attributed to coronary artery disease (CAD). Current guidelines recommend screening with non-invasive modalities in patients with risk factors.…
  • 2019 American Transplant Congress

    Screening for Renal Cell Masses in Kidney Transplant

    H. E. Fernandez, D. Tsapepas, D. J. Cohen, M. Sumit, L. E. Ratner

    Columbia University MC, New York, NY

    *Purpose: End-stage renal disease (ESRD) is a risk factor for development of acquired cystic kidney disease (ACKD) with the incidence of ACKD rising from 90%…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 16
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences